{"entity":{"type":"insider","cik":"0001844824","url":"/insider/0001844824","json_url":"/insider/0001844824.json","name":"SUMER JACQUELYN L","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":12,"first":"2022-06-02","last":"2026-02-25","span_basis":"filed_date"},"name_variants":[{"name":"SUMER JACQUELYN L","source":"filing","n_filings":12,"first_seen":"2022-06-02","last_seen":"2026-02-25"}],"transactions":[{"id":5809565,"accession":"0001193125-26-071997","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-071997","line_url":"/filing/0001193125-26-071997#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Therapeutics, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001844824","owner_name":"SUMER JACQUELYN L","owner_display_name":"SUMER JACQUELYN L","owner_url":"/insider/0001844824","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3601.0,"shares_display":"3,601","price_per_share":14.47,"price_display":"14.47","price_state":"stated","total_value":52106.47,"total_display":"52,106.47","total_whole":"52,106","shares_owned_after":128089.0,"shares_owned_after_display":"128,089","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-24","filed_date":"2026-02-25","scope":"insider"},{"id":6171183,"accession":"0001193125-26-064255","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-064255","line_url":"/filing/0001193125-26-064255#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Therapeutics, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001844824","owner_name":"SUMER JACQUELYN L","owner_display_name":"SUMER JACQUELYN L","owner_url":"/insider/0001844824","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3742.0,"shares_display":"3,742","price_per_share":13.62,"price_display":"13.62","price_state":"stated","total_value":50966.04,"total_display":"50,966.04","total_whole":"50,966","shares_owned_after":131690.0,"shares_owned_after_display":"131,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-20","filed_date":"2026-02-23","scope":"insider"},{"id":4230796,"accession":"0001193125-25-327033","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-327033","line_url":"/filing/0001193125-25-327033#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Therapeutics, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001844824","owner_name":"SUMER JACQUELYN L","owner_display_name":"SUMER JACQUELYN L","owner_url":"/insider/0001844824","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3480.0,"shares_display":"3,480","price_per_share":9.67,"price_display":"9.67","price_state":"stated","total_value":33651.6,"total_display":"33,651.60","total_whole":"33,652","shares_owned_after":135432.0,"shares_owned_after_display":"135,432","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-18","filed_date":"2025-12-19","scope":"insider"},{"id":4263585,"accession":"0000950170-25-029197","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-029197","line_url":"/filing/0000950170-25-029197#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Therapeutics, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001844824","owner_name":"SUMER JACQUELYN L","owner_display_name":"SUMER JACQUELYN L","owner_url":"/insider/0001844824","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3756.0,"shares_display":"3,756","price_per_share":8.53,"price_display":"8.53","price_state":"stated","total_value":32038.68,"total_display":"32,038.68","total_whole":"32,039","shares_owned_after":136895.0,"shares_owned_after_display":"136,895","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-25","filed_date":"2025-02-27","scope":"insider"},{"id":3153062,"accession":"0000950170-24-139123","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-139123","line_url":"/filing/0000950170-24-139123#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Therapeutics, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001844824","owner_name":"SUMER JACQUELYN L","owner_display_name":"SUMER JACQUELYN L","owner_url":"/insider/0001844824","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3482.0,"shares_display":"3,482","price_per_share":11.41,"price_display":"11.41","price_state":"stated","total_value":39729.62,"total_display":"39,729.62","total_whole":"39,730","shares_owned_after":90651.0,"shares_owned_after_display":"90,651","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-18","filed_date":"2024-12-20","scope":"insider"},{"id":8040599,"accession":"0000950170-23-072755","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-072755","line_url":"/filing/0000950170-23-072755#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001844824","owner_name":"SUMER JACQUELYN L","owner_display_name":"SUMER JACQUELYN L","owner_url":"/insider/0001844824","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400.0,"shares_display":"1,400","price_per_share":8.5,"price_display":"8.50","price_state":"stated","total_value":11900.0,"total_display":"11,900.00","total_whole":"11,900","shares_owned_after":44133.0,"shares_owned_after_display":"44,133","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-21","filed_date":"2023-12-22","scope":"insider"},{"id":8251147,"accession":"0000950170-23-071986","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-071986","line_url":"/filing/0000950170-23-071986#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001844824","owner_name":"SUMER JACQUELYN L","owner_display_name":"SUMER JACQUELYN L","owner_url":"/insider/0001844824","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":290.0,"shares_display":"290","price_per_share":8.22,"price_display":"8.22","price_state":"stated","total_value":2383.8,"total_display":"2,383.80","total_whole":"2,384","shares_owned_after":45533.0,"shares_owned_after_display":"45,533","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-18","filed_date":"2023-12-20","scope":"insider"},{"id":8216513,"accession":"0000950170-23-029157","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-029157","line_url":"/filing/0000950170-23-029157#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001844824","owner_name":"SUMER JACQUELYN L","owner_display_name":"SUMER JACQUELYN L","owner_url":"/insider/0001844824","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":291.0,"shares_display":"291","price_per_share":12.94,"price_display":"12.94","price_state":"stated","total_value":3765.54,"total_display":"3,765.54","total_whole":"3,766","shares_owned_after":45823.0,"shares_owned_after_display":"45,823","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-20","filed_date":"2023-06-21","scope":"insider"},{"id":8644667,"accession":"0000899243-23-013360","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-013360","line_url":"/filing/0000899243-23-013360#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001844824","owner_name":"SUMER JACQUELYN L","owner_display_name":"SUMER JACQUELYN L","owner_url":"/insider/0001844824","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":291.0,"shares_display":"291","price_per_share":8.76,"price_display":"8.76","price_state":"stated","total_value":2549.16,"total_display":"2,549.16","total_whole":"2,549","shares_owned_after":46114.0,"shares_owned_after_display":"46,114","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-18","filed_date":"2023-05-19","scope":"insider"},{"id":8645908,"accession":"0000950170-23-013697","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-013697","line_url":"/filing/0000950170-23-013697#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001844824","owner_name":"SUMER JACQUELYN L","owner_display_name":"SUMER JACQUELYN L","owner_url":"/insider/0001844824","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":290.0,"shares_display":"290","price_per_share":10.71,"price_display":"10.71","price_state":"stated","total_value":3105.9,"total_display":"3,105.90","total_whole":"3,106","shares_owned_after":46405.0,"shares_owned_after_display":"46,405","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-18","filed_date":"2023-04-20","scope":"insider"},{"id":8569359,"accession":"0000899243-23-009715","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-009715","line_url":"/filing/0000899243-23-009715#line-1","is_derivative":false,"issuer_cik":"0001789972","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001789972","owner_cik":"0001844824","owner_name":"SUMER JACQUELYN L","owner_display_name":"SUMER JACQUELYN L","owner_url":"/insider/0001844824","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":305.0,"shares_display":"305","price_per_share":11.32,"price_display":"11.32","price_state":"stated","total_value":3452.6,"total_display":"3,452.60","total_whole":"3,453","shares_owned_after":46695.0,"shares_owned_after_display":"46,695","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-20","filed_date":"2023-03-27","scope":"insider"},{"id":6513725,"accession":"0001457612-22-000070","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001457612-22-000070","line_url":"/filing/0001457612-22-000070#line-1","is_derivative":false,"issuer_cik":"0001457612","issuer_name":"GENOCEA BIOSCIENCES, INC.","issuer_ticker":"GNCA","issuer_name_source":null,"issuer_url":"/issuer/0001457612","owner_cik":"0001844824","owner_name":"SUMER JACQUELYN L","owner_display_name":"SUMER JACQUELYN L","owner_url":"/insider/0001844824","role":"Officer (CHIEF LEGAL & COMPLIANCE OFF)","role_mark":"O","role_mark_label":"Officer (CHIEF LEGAL & COMPLIANCE OFF)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF LEGAL & COMPLIANCE OFF","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":0.0601,"price_display":"0.06","price_state":"stated","total_value":150.25,"total_display":"150.25","total_whole":"150","shares_owned_after":43000.0,"shares_owned_after_display":"43,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-01","filed_date":"2022-06-02","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001789972","name":"Cullinan Therapeutics, Inc.","url":"/issuer/0001789972","role":"Officer (Chief Legal Officer)","n_filings":11,"first_seen":"2023-03-27","last_seen":"2026-02-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001457612","name":"GENOCEA BIOSCIENCES, INC.","url":"/issuer/0001457612","role":"Officer (CHIEF LEGAL & COMPLIANCE OFF)","n_filings":1,"first_seen":"2022-06-02","last_seen":"2022-06-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001844824","retrieved_at":"2026-08-27T15:43:27+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}